2026-23541NoticeWallet

FDA Seeks Comments on Lab Rules for Pre-Market Product Studies

Published Date: 11/19/2026

Notice

Summary

The FDA is asking for public feedback on extending rules that make sure lab studies on food additives, drugs, and medical devices are done right and safely. This affects companies testing products before they hit the market, helping protect consumers without adding new costs. Comments are open until December 21, 2026, so now’s the time to weigh in!

Analyzed Economic Effects

2 provisions identified: 1 benefits, 1 costs, 0 mixed.

GLP Recordkeeping and Reporting Continued

If you sponsor or run nonclinical laboratory studies for products regulated by FDA (food additives, human drugs and biological products, animal drugs, or medical devices), you must continue to follow the Good Laboratory Practice rules in 21 CFR part 58 and retain required records and prepare final study reports. FDA estimates there are 300 respondents and that the collection requires 517,849 annual reporting hours and 786,308 annual recordkeeping hours in total across respondents.

No Capital or O&M Costs for GLP Collection

FDA states there are no capital costs or operating and maintenance (O&M) costs associated with this information collection (OMB control number 0910-0119). The agency is retaining the currently approved burden estimates rather than adding new cost categories.

Personalized for You

How does this regulation affect your finances?

Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Key Dates

Published Date
Comments Due
11/19/2026
12/21/2026

Department and Agencies

Department
Independent Agency
Agency
Health and Human Services Department
Food and Drug Administration
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register